Top Markets
Coin of the day
GeneTether Therapeutics Inc. GeneTether Therapeutics Inc.

GeneTether Therapeutics Inc.

GTTX
Rank in Stocks #34708
GeneTether Therapeutics Inc. (GTTX.CN) is a biotechnology firm specializing in... GeneTether Therapeutics Inc. (GTTX.CN) is a biotechnology firm specializing in genetic medicines. Its primary focus is the advancement of gene-editing therapies, aiming to significantly boost the effectiveness of current genomic modification techniques. The company's pipeline is dedicated to engineering genetic treatments for individuals suffering from rare, single-gene disorders affecting the kidneys and skin. Established in 2018, GeneTether Therapeutics Inc. is headquartered in Kelowna, Canada.
Share Price
$0.10409799
Last synced: 2025-02-03
Market Cap
$5.07M
Change (1 day)
16.43%
Change (1 year)
0.00%
Country
CA
Trade GeneTether Therapeutics Inc. (GTTX)

Category

Dividend yield history for GeneTether Therapeutics Inc. (GTTX)
GeneTether Therapeutics Inc. (stock symbol: GTTX) dividend yield (TTM) as of 2026: 0
Average dividend yield, last 5 years : 0.00%
Dividend yield history for GeneTether Therapeutics Inc. (GTTX) from 2026 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
Not enough data for the provided dates.
Dividend yields (TTM) for similar companies or competitors